VOGLIGOLD M 0.2: Uses, Side effect, Interactions, Dosage, ETC......

VOGLIGOLD M 0.2

Voglibose 0.2 mg + Metformin SR 500

VOGLIGOLD M 0.2 is a combination medication designed to offer enhanced control of blood sugar levels in patients with type 2 diabetes. It brings together Voglibose 0.2 mg + Metformin SR 500 (Sustained Release), two powerful agents with complementary actions.

Mechanism of Action

• Voglibose (0.2 mg): Voglibose is an alpha-glucosidase inhibitor that works by slowing down the digestion and absorption of carbohydrates in the intestines. This action helps in reducing post-meal glucose spikes.
• Metformin SR (500 mg): Metformin acts primarily by reducing glucose production in the liver and improving insulin sensitivity. The sustained-release formulation ensures a gradual release of the medication, providing stable blood sugar control throughout the day.

Benefits of VOGLIGOLD M 0.2

• Improved Postprandial Blood Sugar: Voglibose’s ability to inhibit carbohydrate breakdown effectively controls blood sugar spikes after meals.
• Extended Glycemic Control: Metformin SR helps in maintaining stable blood glucose levels, reducing the risk of complications associated with diabetes.
• Enhanced Patient Compliance: The combination of two antidiabetic drugs in one tablet simplifies the treatment regimen, improving adherence.

Recommended Dosage The typical dosage of VOGLIGOLD M 0.2 is one tablet taken with meals, usually starting with the first meal of the day. Patients are advised to follow their healthcare provider’s instructions to adjust the dosage based on their specific health needs.

Potential Side Effects Common side effects may include gastrointestinal symptoms such as bloating and gas due to Voglibose and nausea or diarrhea from Metformin. Long-term use requires monitoring of liver function and kidney health.

Conclusion VOGLIGOLD M 0.2 offers a strategic combination of Voglibose and Metformin SR, targeting different aspects of diabetes management to optimize blood sugar control and minimize risks of diabetes-related complications.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW